Year-End Report — NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION (2007)

Firm

NATIONAL PATIENT ADVOCATE FOUNDATION

Client

NATIONAL PATIENT ADVOCATE FOUNDATION

Income

—

Expenses

$288,125

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

patent reform

Lobbyist	Covered position, as disclosed
EMILY BROWN	N/A
NANCY DAVENPORT-ENNIS	N/A
JIM GOTTLIEB	N/A
AMY WOTRING	N/A

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

SCHIP; Medicare Reimbursement

Lobbyist	Covered position, as disclosed
EMILY BROWN	N/A
NANCY DAVENPORT-ENNIS	N/A
JIM GOTTLIEB	N/A
AMY WOTRING	N/A

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Labor-HHS Appropriations; Agriculture Appropriations

Lobbyist	Covered position, as disclosed
EMILY BROWN	N/A
NANCY DAVENPORT-ENNIS	N/A
JIM GOTTLIEB	N/A
AMY WOTRING	N/A

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Insurance INS

Pre-existing condition; health care reform

Lobbyist	Covered position, as disclosed
EMILY BROWN	N/A
NANCY DAVENPORT-ENNIS	N/A
JIM GOTTLIEB	N/A
AMY WOTRING	N/A

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

Health information technology; e-prescribing; small business health reform; Medicare reimbursement; pre-existing condition; cancer clinical trials; comparative effectiveness; biogenerics/biologics; medical imaging; prescription drug reimportation; SCHIP; patient navigator; stem cell research; Social Security Disability Waiting Period; and FDA drug safety.

Lobbyist	Covered position, as disclosed
EMILY BROWN	N/A
NANCY DAVENPORT-ENNIS	N/A
JIM GOTTLIEB	N/A
AMY WOTRING	N/A

Contacted: SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.